Zomedica Pharmaceuticals's total assets for Q3 2025 were $214.12M, a decrease of -2.62% from the previous quarter. ZOM total liabilities were $11.27M for the fiscal quarter, a 0.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.